{"id":"W3121188369","doi":"10.1200/jco.2021.39.3_suppl.269","title":"Nivolumab (NIVO) plus ipilimumab (IPI) combination therapy in patients (Pts) with advanced hepatocellular carcinoma (aHCC): Long-term results from CheckMate 040.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Tolerability; Hepatocellular carcinoma; Gastroenterology; Cohort; Nivolumab; Sorafenib; Surgery; Adverse effect; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001086814,0.0005265433,0.0009863258,0.0002535218,0.000243289,0.0007401356,0.0004646084,0.0005048686,0.002601826],"category_scores_gemma":[0.0006099432,0.0002437719,0.001052273,0.000372791,0.0004093932,0.0004977396,0.0002669147,0.001338703,0.0005927224],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001057724,"about_ca_system_score_gemma":0.0007663132,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008311116,"about_ca_topic_score_gemma":0.002665664,"domain_scores_codex":[0.9997017,0.0001223175,0.00002775631,0.00005897401,0.00004060354,0.00004861119],"domain_scores_gemma":[0.9995781,0.00007656702,0.0001033221,0.0000370046,0.00002408953,0.0001809902],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7049488,0.0232419,0.02516294,0.00176462,0.00300332,0.0003387073,0.000204918,0.003478155,0.02285921,0.0001828313,0.007229326,0.2075853],"study_design_scores_gemma":[0.2648103,0.6038227,0.1022538,0.0001894252,0.003652162,0.0008137981,0.0001072252,0.003425236,0.008337915,0.0002979881,0.01218388,0.0001055195],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9907204,0.004760358,0.0003465246,0.0002156067,0.00007421157,0.0006281107,0.001492539,0.000047822,0.001714437],"genre_scores_gemma":[0.9924436,0.001909725,0.0005931067,0.0004376672,0.00008985676,0.0005090543,0.002507137,0.00001280625,0.001497014],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002601826,"threshold_uncertainty_score":0.008704007,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1171710268475665,"score_gpt":0.3630653277769076,"score_spread":0.2458943009293411,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}